Vaccination of the elderly: An update;Praktijkgerichte geriatrische bijdrage - Vaccinaties en ouderen: Een update

Tijdschrift voor Gerontologie en Geriatrie

Volumn 36, Issue 5, 2005, Pages 203-208

  Carels, T ^b   Flamaing, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

AGED; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHILD HEALTH CARE; CHRONIC OBSTRUCTIVE LUNG DISEASE; ELDERLY CARE; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; REVIEW; RISK REDUCTION; STREPTOCOCCUS INFECTION; TETANUS; TETANUS PROPHYLAXIS; VACCINATION; VIRUS TRANSMISSION; BELGIUM; FEMALE; HEALTH SURVEY; MALE; NETHERLANDS; RISK FACTOR; UTILIZATION REVIEW;

PNEUMOCOCCUS; STREPTOCOCCUS;

AGED; BELGIUM; FEMALE; HEALTH SERVICES FOR THE AGED; HUMANS; INFLUENZA VACCINES; MALE; NETHERLANDS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; RISK FACTORS; TETANUS TOXOID; VACCINATION;

EID: 27844606801     PISSN: 01679228     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Pascual F B, McGinley EL, Zanardi LR, Cortese MM, Murphy TV. Tetanus Surveillance United States, 1998-2000. MMWR 2003;52 (SS03):1-8.
2. Gezondheidsenquête door middel van interview België 2001. http://www.iph.fgov.be/sasweb/his/nl/index.htm
3. Peetermans WE, Schepens D. Tetanus - still a topic of present interest: a report of 27 cases from a Belgian referral hospital. J Intern Med 1996;239:249-252.
4. Sanford JP, Gilbert DN, Moellering RC, Sande MA. In The Sanford guide to antimicrobial therapy 2003-2004 p234 and p250.
5. Vaccinatie tegen Tetanus (2002) - HGR 5231 http://www.health. fgov.be/CSH_HGR/Nederlands/lijstvanadvies_en_brochures.htm#V
6. Gezondheidsraad. Immunisatie bij tetanus bij verwonding. Den Haag: Gezondheidsraad, 2003; publicatienr 2003/10.
7. Hardy IR, Dittmann S, Sutter RW. Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet. 1996;347:1739-44.
8. Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A, Abrams K. Systematic review and economic decision modeling for the prevention and treatment of influenza A an B. http://www.nice.org.uk/pdf/influenzaassrep.pdf
9. Govaert TM, Thijs CT, Masurel M, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. JAMA 1994;272:1661-1665.
10. Gross PA, Hermogenes AW, Sacks HS, Lauw J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995;123:518-527.
11. Vu T, Parish S, Jenkins S, Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002;20:1831-1836.
12. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalisation for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-1332.
13. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalisation, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999;130:397-403.
14. Banzhoff A, Nacci P, Podda A. A new MF59-adjuvated influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis. Gerontology 2003;49:177-184
15. Beyer WE, Palache AM, de Jong JC, Osterhaus AD. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 2002;20:1340-53.
16. Stepanova L, Naykhin A, Kolmskog C, et al. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. Clin Virol 2002;24:193-201.
17. Treanor JJ, Betts RF. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects. Vaccine 1998;16:1756-60
18. Arden N, Monto AS, Ohmit SE. Vaccine use and the risk of outbreaks in a sample of nursing homes during an influenza epidemic. Am J Publ Health 1995;85:399-401.
19. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 2000;355:93-97.
20. Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 2001;344:889-96
21. Gezondheidsraad. Vaccinatie tegen influenza seizoen 1996-1997. Rijswijk: Gezondheidsraad, 1996; publicatienr 1996/13.
22. Cools HJM, Herngreen JJ, de Jong RE, Lichtenbelt MF, Rothbarth PH, van Essen GA, NWA-Richtlijn: Influenzapreventie in verpleeghuizen en verzorgingshuizen; ISBN nr. 90 807332 3 7. http:// nvva.artscnnet.nl/
23. Vaccinatie tegen Influenza (2002) - HGR 5231. http://www.health.fgov.be/ CSH_HGR/Nederlands/lijstvanadvies_en_brochures.htm#V
24. Belgisch Centrum voor Farmacotherapeutische Informatie. http://www.bcfi.be
25. Farmacotherapeutisch Kompas. http://www.cvzkompassen.nl/fk/
26. Plouffe JF, Breiman RR, Facklamm RR. Bacteremia with Streptococcus pneumoniae in adults: implications for therapy and prevention. JAMA 1996;275:194-198.
27. Flamaing J, Verhaegen J, Peetermans WE. Streptococcus pneumoniae bacteraemia in Belgium: differential characteristics in children and the elderly and implications for vaccine use. J Antimicrob Chemother 2002;50:43-50.
28. Dear K, Holden J, Andrews R, Tatham D. Vaccines for preventing pneumococcal infection in adults (Cochrane Review). In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.
29. Black S, Shinefield H, Fireman B, et al. Efficacy, safety, and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000;19:187-195.
30. Christenson B, Hedlund J, Lundbergh P, Örtqvist A. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004;363-368.
31. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999;17:S91-S93
32. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J 2002;21:810-815.
33. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 2003;22:10-16.
34. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of pneumococcal conjugate vaccine followed by polysaccharide pneumococcal vaccine on recurrent otitis media: a randomised study. Lancet 2003;361:2189-2195
35. Dagan R, Givon-Lavi N, Zamir O, Fraser D. Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 2003;22:532-540.
36. Artz AS, Ershler WB, Longo DL. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev 2003;16:308-318.
37. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-1746.
38. Vaccinatie tegen Pneumokokken (2004) - HGR 5231. http://www.health.fgov. be/CSHJHGR/Nederlands/lijstvanadvies_en_brochures.htm#V
39. Gezondheidsraad. Vaccinatie tegen pneumokokken bij ouderen en risicogroepen. Den Haag: Gezondheidsraad, 2003; publicatie nr 2003/10.